136 related articles for article (PubMed ID: 12124476)
1. Biodistribution and dosimetry of [(18)F]fluorodeoxyglucose labelled leukocytes in normal human subjects.
Forstrom LA; Dunn WL; Mullan BP; Hung JC; Lowe VJ; Thorson LM
Nucl Med Commun; 2002 Aug; 23(8):721-5. PubMed ID: 12124476
[TBL] [Abstract][Full Text] [Related]
2. Inflammation and infection: imaging properties of 18F-FDG-labeled white blood cells versus 18F-FDG.
Pellegrino D; Bonab AA; Dragotakes SC; Pitman JT; Mariani G; Carter EA
J Nucl Med; 2005 Sep; 46(9):1522-30. PubMed ID: 16157536
[TBL] [Abstract][Full Text] [Related]
3. Retro-orbital injection is an effective route for radiopharmaceutical administration in mice during small-animal PET studies.
Nanni C; Pettinato C; Ambrosini V; Spinelli A; Trespidi S; Rubello D; Al-Nahhas A; Franchi R; Alavi A; Fanti S
Nucl Med Commun; 2007 Jul; 28(7):547-53. PubMed ID: 17538396
[TBL] [Abstract][Full Text] [Related]
4. Estimation of absorbed dose for 2-[F-18]fluoro-2-deoxy-D-glucose using whole-body positron emission tomography and magnetic resonance imaging.
Deloar HM; Fujiwara T; Shidahara M; Nakamura T; Watabe H; Narita Y; Itoh M; Miyake M; Watanuki S
Eur J Nucl Med; 1998 Jun; 25(6):565-74. PubMed ID: 9618570
[TBL] [Abstract][Full Text] [Related]
5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
6. Standardized uptake values for [¹⁸F] FDG in normal organ tissues: comparison of whole-body PET/CT and PET/MRI.
Heusch P; Buchbender C; Beiderwellen K; Nensa F; Hartung-Knemeyer V; Lauenstein TC; Bockisch A; Forsting M; Antoch G; Heusner TA
Eur J Radiol; 2013 May; 82(5):870-6. PubMed ID: 23394765
[TBL] [Abstract][Full Text] [Related]
7. Effects of anesthetic agents and fasting duration on 18F-FDG biodistribution and insulin levels in tumor-bearing mice.
Lee KH; Ko BH; Paik JY; Jung KH; Choe YS; Choi Y; Kim BT
J Nucl Med; 2005 Sep; 46(9):1531-6. PubMed ID: 16157537
[TBL] [Abstract][Full Text] [Related]
8. Defining optimal tracer activities in pediatric oncologic whole-body
Gatidis S; Schmidt H; la Fougère C; Nikolaou K; Schwenzer NF; Schäfer JF
Eur J Nucl Med Mol Imaging; 2016 Dec; 43(13):2283-2289. PubMed ID: 27565153
[TBL] [Abstract][Full Text] [Related]
9. PET with FDG-labeled leukocytes versus scintigraphy with 111In-oxine-labeled leukocytes for detection of infection.
Rini JN; Bhargava KK; Tronco GG; Singer C; Caprioli R; Marwin SE; Richardson HL; Nichols KJ; Pugliese PV; Palestro CJ
Radiology; 2006 Mar; 238(3):978-87. PubMed ID: 16505395
[TBL] [Abstract][Full Text] [Related]
10. Optimal dose of 18F-FDG required for whole-body PET using an LSO PET camera.
Everaert H; Vanhove C; Lahoutte T; Muylle K; Caveliers V; Bossuyt A; Franken PR
Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):1615-9. PubMed ID: 14504831
[TBL] [Abstract][Full Text] [Related]
11. Biodistribution and radiation dosimetry of stabilized 99mTc-exametazine-labeled leukocytes in normal subjects.
Robins PD; Salazar I; Forstrom LA; Mullan BP; Hung JC
J Nucl Med; 2000 May; 41(5):934-40. PubMed ID: 10809211
[TBL] [Abstract][Full Text] [Related]
12. Human Radiation Dosimetry for Orally and Intravenously Administered
Srinivasan S; Crandall JP; Gajwani P; Sgouros G; Mena E; Lodge MA; Wahl RL
J Nucl Med; 2020 Apr; 61(4):613-619. PubMed ID: 31628217
[TBL] [Abstract][Full Text] [Related]
13. Myocardial distribution of (18)F-FDG and (99m)Tc-sestamibi on dual-isotope simultaneous acquisition SPET compared with PET.
Matsunari I; Kanayama S; Yoneyama T; Matsudaira M; Nakajima K; Taki J; Nekolla SG; Takekoshi N; Tonami N; Hisada K
Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1357-64. PubMed ID: 12271419
[TBL] [Abstract][Full Text] [Related]
14. Whole-body tumor imaging using PET and 2-18F-fluoro-L-tyrosine: preliminary evaluation and comparison with 18F-FDG.
Hustinx R; Lemaire C; Jerusalem G; Moreau P; Cataldo D; Duysinx B; Aerts J; Fassotte MF; Foidart J; Luxen A
J Nucl Med; 2003 Apr; 44(4):533-9. PubMed ID: 12679396
[TBL] [Abstract][Full Text] [Related]
15. Biodistribution and radiation dosimetry of 18F-fluoro-A-85380 in healthy volunteers.
Bottlaender M; Valette H; Roumenov D; Dollé F; Coulon C; Ottaviani M; Hinnen F; Ricard M
J Nucl Med; 2003 Apr; 44(4):596-601. PubMed ID: 12679405
[TBL] [Abstract][Full Text] [Related]
16. FDG-PET, 99mtc-HMPAO white blood cell SPET and bone scintigraphy in the evaluation of painful total knee arthroplasties.
Van Acker F; Nuyts J; Maes A; Vanquickenborne B; Stuyck J; Bellemans J; Vleugels S; Bormans G; Mortelmans L
Eur J Nucl Med; 2001 Oct; 28(10):1496-504. PubMed ID: 11685492
[TBL] [Abstract][Full Text] [Related]
17. Whole-body biodistribution and radiation dosimetry of the human cannabinoid type-1 receptor ligand 18F-MK-9470 in healthy subjects.
Van Laere K; Koole M; Sanabria Bohorquez SM; Goffin K; Guenther I; Belanger MJ; Cote J; Rothenberg P; De Lepeleire I; Grachev ID; Hargreaves RJ; Bormans G; Burns HD
J Nucl Med; 2008 Mar; 49(3):439-45. PubMed ID: 18287275
[TBL] [Abstract][Full Text] [Related]
18. Imaging of experimental colitis with a radiolabeled leukotriene B4 antagonist.
van Eerd JE; Laverman P; Oyen WJ; Harris TD; Edwards DS; Ellars CE; Corstens FH; Boerman OC
J Nucl Med; 2004 Jan; 45(1):89-93. PubMed ID: 14734679
[TBL] [Abstract][Full Text] [Related]
19. 18F-FDG labelling of human leukocytes.
Forstrom LA; Mullan BP; Hung JC; Lowe VJ; Thorson LM
Nucl Med Commun; 2000 Jul; 21(7):691-4. PubMed ID: 10994674
[TBL] [Abstract][Full Text] [Related]
20. Towards real-time topical detection and characterization of FDG dose infiltration prior to PET imaging.
Williams JM; Arlinghaus LR; Rani SD; Shone MD; Abramson VG; Pendyala P; Chakravarthy AB; Gorge WJ; Knowland JG; Lattanze RK; Perrin SR; Scarantino CW; Townsend DW; Abramson RG; Yankeelov TE
Eur J Nucl Med Mol Imaging; 2016 Dec; 43(13):2374-2380. PubMed ID: 27557845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
